Analyst Price Targets — CBT
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| August 5, 2026 1:00 pm | — | UBS | $92.00 | $81.58 | TheFly | Cabot price target lowered to $92 from $97 at UBS |
| August 5, 2026 12:41 pm | — | Truist Financial | $100.00 | $81.39 | TheFly | Cabot price target raised to $100 from $98 at Truist |
| June 25, 2026 11:22 am | — | Mizuho Securities | $90.00 | $91.89 | TheFly | Cabot price target raised to $90 from $80 at Mizuho |
| June 8, 2026 10:24 am | — | Truist Financial | $98.00 | $80.88 | TheFly | Cabot initiated with a Buy at Truist |
| May 8, 2026 2:43 pm | — | UBS | $86.00 | $84.70 | TheFly | Cabot price target raised to $86 from $81 at UBS |
| February 4, 2026 9:51 pm | — | Mizuho Securities | $75.00 | $78.73 | TheFly | Cabot downgraded to Neutral from Outperform at Mizuho |
| February 4, 2026 9:12 pm | Laurence Alexander | Jefferies | $85.00 | $78.73 | StreetInsider | Cabot Corp. (CBT) PT Raised to $85 at Jefferies |
| January 12, 2026 2:06 pm | Joshua Spector | UBS | $74.00 | $72.96 | TheFly | Cabot price target lowered to $74 from $75 at UBS |
| January 8, 2026 7:30 pm | — | UBS | $81.00 | $71.89 | TheFly | Cabot price target raised to $81 from $79 at Jefferies |
| January 8, 2026 7:26 pm | Laurence Alexander | Jefferies | $81.00 | $71.80 | StreetInsider | Cabot Corp. (CBT) PT Raised to $81 at Jefferies |
Latest News for CBT
Cabot (CBT) reported earnings 30 days ago. What's next for the stock?
CBT is riding battery-materials growth, circular products and capacity expansion, even as weaker pricing and rising costs pressure profitability.
BOSTON, Aug. 12, 2026 (GLOBE NEWSWIRE) -- Cabot Corporation (NYSE: CBT) today announced that it priced a public offering of $350 million of 4.950% senior unsecured notes due 2029. The notes are being sold to the public at a price of 99.993% of the face amount thereof.
Cabot's Q3 fiscal 2026 earnings beat estimates as Performance Chemicals gains offset Reinforcement Materials margin pressure.
Cabot NYSE: CBT reported third-quarter fiscal 2026 adjusted earnings per share of $1.67, up 4% sequentially, as strength in its Performance Chemicals segment helped offset lower earnings in Reinforcement Materials.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
Senate Trading Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
U.S. House Trading
No House trades found for CBT.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.